2006
DOI: 10.1111/j.1423-0410.2005.00731.x
|View full text |Cite
|
Sign up to set email alerts
|

A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance

Abstract: The new process gives pure and stable IgG solution with an average yield of 4.8 g of IgG per kg of recovered plasma and has a very high capacity to remove even physico-chemically resistant viruses.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
50
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(50 citation statements)
references
References 42 publications
(39 reference statements)
0
50
0
Order By: Relevance
“…PEI and caprylic acid have been implemented in microbial [37] and plasma processes [12,13,28], respectively. Acid precipitation and PDADMAC are being Industrial application of flocculation Review implemented in mAb production at large scale.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…PEI and caprylic acid have been implemented in microbial [37] and plasma processes [12,13,28], respectively. Acid precipitation and PDADMAC are being Industrial application of flocculation Review implemented in mAb production at large scale.…”
Section: Discussionmentioning
confidence: 99%
“…It has been used effectively to precipitate nonimmunoglobulin protein impurities from serum, plasma and ascites fluid [13,25,26]. It was also reported as an effective agent for inactivating enveloped viruses [27][28][29].…”
Section: Caprylic Acid Treatmentmentioning
confidence: 98%
See 1 more Smart Citation
“…The technique relies on caprylic (octanoic) acid precipitation of non-Ig molecules [14,15]. Caprylic acid is already used to prepare licensed IgG or IgM preparations from precipitates II+III [16,17], II [18], or III [18]; 5%-pH 5.5 caprylic acid precipitation is also used to produce horse plasma-derived therapeutic antivenom immunoglobulins [19,20], and this process may become an alternative to chromatography for monoclonal antibodies production [21]. …”
Section: Discussionmentioning
confidence: 99%
“…The p19 fragment remains attached to the merozoite surface through a GPI anchor (Gerold et al, 1996) and is comprised of two epidermal growth factor (EGF)-like domains (Morgan et al, 1999), which may have a role in the invading complex. Serological studies have provided significant evidence suggesting that immune responses directed against the C-terminus of MSP-1 (MSP-1p19 and MSP-1p42) are associated with immunity in preclinical models (Long et al, 1994;Egan et al, 1999;Darko et al, 2005;Parkkinen et al, 2006). Moreover, protective immunity as defined by lower mortality and morbidity of individuals residing in endemic areas was also associated with MSP-1p19 (Egan et al, 1999;John et al, 2004).…”
Section: Msp-1 and Its Role In Immunity And Infectionmentioning
confidence: 99%